Form 4 holding
Executive Vice President, Global R&D and Chief Medical Officer
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Ordinary Shares
- Shares / value
- 107,711
- Estimated value
- $3,411,035
- Report date
- 05 Mar 2026
- Price
- $31.67
- Ownership
- Direct